1 - Got the stomach for this sin-stock?
The current price, £26.82, values BATS at just eight-times this year’s earnings, falling to 7.5-times and then 6.9-times. That’s the bargain-bucket stuff – if you don’t mind owning tobacco.
2 - AstraZeneca buys into Californian Phase III heart drug
The Anglo-Swedish has agreed a US$3.5bn drug licencing deal that’s potentially nearly as much as the market capitalisation of the Californian biotech it is teaming up with.
3 - FTSE sees strong rebound
At the close, the UK blue-chip index was up 107.62, or 1.5% at 7,339.90, just below the day's peak of 7,344.69 and well above the session low of 7,232.28
4 - Cardano, Solana and Ethereum outpace Bitcoin
Cryptos are back on the front foot, but still have plenty of catching up to do.
5 - Stockbroker eyes Jubliee Metals growth engine
Jubilee’s next growth engine is expected to come from Zambia, where it is targeting copper production of more than 31,000 tonnes per year from two refineries, that’s according to broker WH Ireland.
Another thing … cannabis tech and PE treatments, and Glaxo’s COVID drug effective against omicron variant.
The day ahead: Wednesday
Finals – Hardide PLC (AIM:HDD), SSP Group plc (LSE:SSPG), TUI
Interims- Berkeley Group Holdings PLC, Ince Group PLC, Quiz PLC (AIM:QUIZ), Stagecoach PLC
Trading announcements- McColls Retail Group PLC
AGMs- Alternative Liquidity Fund Ltd, Ashoka India Equity Investment Trust PLC (LSE:AIE), Europa Oil & Gas Holdings, International Biotechnology Trust plc, Volta Finance Ltd
Economic announcements- MBA Mortgage application (US), Crude Oil Inventories (US)